These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11976926)
1. Dehydration modifies guanidino compound concentrations in the different zones of the rat kidney. Levillain O; Marescau B; Possemiers I; De Deyn P Pflugers Arch; 2002 May; 444(1-2):143-52. PubMed ID: 11976926 [TBL] [Abstract][Full Text] [Related]
2. Renal handling of guanidino compounds in rat and rabbit. Levillain O; Marescau B; De Deyn PP J Physiol; 1997 Mar; 499 ( Pt 2)(Pt 2):561-70. PubMed ID: 9080382 [TBL] [Abstract][Full Text] [Related]
3. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy. Levillain O; Marescau B; de Deyn PP Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856 [TBL] [Abstract][Full Text] [Related]
4. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study. Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and histopathological changes in nephrectomized mice. Al Banchaabouchi M; Marescau B; D'Hooge R; Van Marck E; Van Daele A; Levillain O; De Deyn PP Metabolism; 1998 Mar; 47(3):355-61. PubMed ID: 9500577 [TBL] [Abstract][Full Text] [Related]
6. Serum creatine, creatinine, and other guanidino compounds in patients with thyroid dysfunction. Verhelst J; Berwaerts J; Marescau B; Abs R; Neels H; Mahler C; De Deyn PP Metabolism; 1997 Sep; 46(9):1063-7. PubMed ID: 9284897 [TBL] [Abstract][Full Text] [Related]
7. Metabolism of arginine by the isolated perfused rat kidney. Perez GO; Epstein M; Rietberg B; Loutzenhiser R Am J Physiol; 1978 Oct; 235(4):F376-80. PubMed ID: 696875 [TBL] [Abstract][Full Text] [Related]
8. Guanidino compound levels in brain regions of non-dialyzed uremic patients. De Deyn PP; Marescau B; D'Hooge R; Possemiers I; Nagler J; Mahler C Neurochem Int; 1995 Sep; 27(3):227-37. PubMed ID: 8520461 [TBL] [Abstract][Full Text] [Related]
9. Effects of starvation on guanidino compound metabolism in mice. Shindo S; Watanabe Y; Mori A Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):73-85. PubMed ID: 3797807 [TBL] [Abstract][Full Text] [Related]
10. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice. Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086 [TBL] [Abstract][Full Text] [Related]
12. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113 [TBL] [Abstract][Full Text] [Related]
13. Plasma, urinary, and erythrocyte concentrations of guanidino compounds in patients with chronic renal failure. Tanaka A; Takahashi Y; Mizokuchi M; Shimada N; Koide H Ren Fail; 1999 Sep; 21(5):499-514. PubMed ID: 10516995 [TBL] [Abstract][Full Text] [Related]
14. Guanidino compounds in serum and brain of audiogenically sensitive rats. Wiechert P; Marescau B; De Deyn P; Lowenthal A Biomed Biochim Acta; 1986; 45(10):1339-42. PubMed ID: 3566723 [TBL] [Abstract][Full Text] [Related]
15. Effect of antidiuresis on renal creatine metabolism. Garcia-Miranda P; Peral MJ; Ilundain AA J Physiol Pharmacol; 2010 Feb; 61(1):83-8. PubMed ID: 20228419 [TBL] [Abstract][Full Text] [Related]
16. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations. De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B Nephron; 1995; 69(4):411-7. PubMed ID: 7777105 [TBL] [Abstract][Full Text] [Related]
17. Biochemical validation of a rat model for polycystic kidney disease: comparison of guanidino compound profile with the human condition. Torremans A; Marescau B; Kränzlin B; Gretz N; Billiouw JM; Vanholder R; De Smet R; Bouwman K; Brouns R; De Deyn PP Kidney Int; 2006 Jun; 69(11):2003-12. PubMed ID: 16641922 [TBL] [Abstract][Full Text] [Related]
18. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure. Sawynok J; Dawborn JK Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056 [TBL] [Abstract][Full Text] [Related]
19. Improved Gas Chromatographic Determination of Guanidino Compounds Using Isovaleroylacetone and Ethyl Chloroformate as Derivatizing Reagents. Zounr RA; Khuhawar MY; Jahangir TM; Alamgir M Anal Sci; 2016; 32(2):141-6. PubMed ID: 26860556 [TBL] [Abstract][Full Text] [Related]
20. Accumulation of methylguanidine and changes in guanidino compound levels in plasma, urine, and kidneys of furosemide-treated rats. Levillain O; Marescau B; Possemiers I; De Deyn PP Metabolism; 2008 Jun; 57(6):802-10. PubMed ID: 18502263 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]